Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
MARSEILLE, France, May 15, 2025--(BUSINESS WIRE)--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that an abstract regarding IPH6501, its ANKET® targeting CD20 B cells currently developed in relapsed and/or refractory Non-Hodgkin Lymphoma, has been selected for the European Hematology Association (EHA) Congress 2025, taking place June 12-15 in Milan, Italy.
Abstract details
Antitumor characterization of IPH6501, a novel il2v-armed tetraspecific NK cell engager targeting CD20 B cells, in DLBCL and FL patient samples, and in preclinical combination with R-CHOP Abstract Code: PS2004Session: Poster session 2Session Date/Time: Saturday, June 14, 2025, 18:30 – 19:30 CESTMore information can be found on the EHA website.
In addition, an abstract related to SAR'514/IPH6401 (developed by Sanofi) was accepted for online publication.
The BCMA NK Cell Engager SAR'514 Induces Macrophage-Mediated Phagocytosis which is improved by combination with Evorpacept, a CD47 Blocker, in Multiple Myeloma Abstract Code: PB2850
About ANKET®
ANKET® (Antibody-based NK cell Engager Therapeutics) is Innate's proprietary platform for developing next-generation, multi-specific natural killer (NK) cell engagers to treat certain types of cancer. This versatile, fit-for-purpose technology is creating an entirely new class of molecules to induce synthetic immunity against cancer.
About IPH6501
IPH6501 is the first Antibody-based NK cell Engager Therapeutic to co-engage activating receptors on NK cells (NKp46 and CD16), IL-2R (but not the alpha subunit) through a variant of human IL-2, and a tumor antigen (CD20) via a single molecule, hence providing proliferation and activation signals targeted to NK cells and promoting their cytotoxic activity against CD20 expressing malignant cells.
IPH6501 has shown better anti-tumor efficacy than approved benchmark antibodies in preclinical tumor models (Demaria, EHA 2023, Carrette, SITC 2024, Demaria et al, Science Immunology 2024).
IPH6501 is currently being evaluated in a Phase 1/2 multicenter trial (NCT06088654), investigating the safety and tolerability of IPH6501 in patients with relapsed and/or refractory CD20-expressing B-cell Non-Hodgkin's Lymphoma.
About Innate Pharma
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: multi-specific NK Cell Engagers via its ANKET® (Antibody-based NK cell Engager Therapeutics) proprietary platform and Antibody Drug Conjugates (ADC) and monoclonal antibodies (mAbs).
Innate's portfolio includes several ANKET® drug candidates to address multiple tumor types as well as IPH4502, a differentiated ADC in development in solid tumors. In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb monalizumab is developed with AstraZeneca in non-small cell lung cancer.
Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients.
Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
Learn more about Innate Pharma at www.innate-pharma.com. Follow us on LinkedIn and X.
Information about Innate Pharma shares
ISIN code Ticker code LEI
FR0010331421
Euronext: IPH Nasdaq: IPHA
9695002Y8420ZB8HJE29
Disclaimer on forward-looking information and risk factors
This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including "anticipate," "believe," "can," "could," "estimate," "expect," "may," "might," "potential," "intend," "should," "will," or the negative of these and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company's reliance on third parties to manufacture its product candidates, the Company's commercialization efforts and the Company's continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties, which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority ("AMF"), which is available on the AMF website http://www.amf-france.org or on Innate Pharma's website, and public filings and reports filed with the U.S. Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 20-F for the year ended December 31, 2024, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company's website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release.
In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250514267623/en/
Contacts
For additional information, please contact:
Investors Innate Pharma Henry WheelerTel.: +33 (0)4 84 90 32 88Henry.wheeler@innate-pharma.fr
Media Relations NewCap Arthur RouilléTel.: +33 (0)1 44 71 00 15innate@newcap.eu
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
18 minutes ago
- Business Insider
Bank of America Weighs in on Amazon Stock Amid Rising Robotics Potential
Amazon (NASDAQ:AMZN) has made several high-profile acquisitions in recent years, including the $13.7 billion purchase of Whole Foods in 2017 and the $8.45 billion acquisition of MGM Studios in 2022. Confident Investing Starts Here: But long before these deals, Amazon made a strategic bet that would quietly redefine its core operations. In 2012, it acquired Kiva Systems for $775 million – a move that laid the foundation for the company's massive push into automation. That early investment has since evolved into a robotics powerhouse, with Amazon now deploying more than 20 types of robots and operating a fleet of over 750,000 units. Although robots are already deeply integrated into Amazon's fulfillment centers, Bank of America's Justin Post, an analyst ranked in the top 1% of Wall Street stock experts, thinks the company is still in the early stages of broader robotics adoption, as evidenced by the late-2024 launch of its automated fulfillment center and the May announcement of eight new robots for delivery stations set to be deployed over the next two years. 'Robots will be instrumental in improving Amazon's long-term cost structure,' says Post, 'likely by: 1) reducing labor dependencies and impact of wage inflation; 2) reducing employee injury costs; 3) increasing order accuracy, and 4) driving higher warehouse utilization.' Post thinks Robotics could strengthen Amazon's 'competitive moats,' especially as increased transparency in an AI-driven retail landscape favors companies with lower costs and faster delivery. According to Amazon, recent AI advancements have brought a 'step change' in how automation can help its employees, opening the door for further logistical innovation. The development of spatially aware robots capable of sorting, picking, and packing represents a 'significant breakthrough' in fulfillment and delivery – one that Amazon is likely to embrace well ahead of rivals, thanks in part to its leadership in AI through AWS. The cost-saving potential of robots is not to be sniffed at. The new 12th-generation fulfillment centers – equipped with 10 times more robots – are expected to reduce peak period service costs by 25%. The multi-year rollout of these advanced centers and retrofitting of existing facilities is underway, after kicking off with the initial one last year. Amazon is also deploying more robots in delivery stations and piloting autonomous drone deliveries in Texas and Arizona. Based on estimated efficiency gains – 20% in new fulfillment centers, 15% in updated delivery stations, and 40% for drone deliveries on select packages – by 2032, Post reckons robotics could generate up to $ 16 billion in annual cost savings. Additionally, there's still a way to go in improving margins. The 2024 retail operating profit margin of 5.4% amounts to a big improvement vs. 2022, and Post thinks that over the long-term, there is potential for margins to reach 11%, based on assumptions of a 55% margin on advertising, 20% on third-party (3P) services, 5% on subscriptions, breakeven for 1P (first-party) retail, and $10 billion in annual investment spending. 'We think robots and drones will increase Amazon's shipping speed advantages, and could add another 2pts to Amazon's long-term retail margins, helping move 1P toward better profitability in a very price-transparent AI world,' Post further said. Conveying his confidence, Post assigns a Buy rating to AMZN shares and raises his price target from $230 to $248, suggesting the stock could gain ~21% in the months ahead. (To watch Post's track record, click here) That is just one of many bullish AMZN takes on Wall Street; the stock's Strong Buy consensus rating is based on a lopsided mix of 47 Buys and 1 Hold. Going by the $240.62 average price target, a year from now, the shares will be changing hands for a 17% premium. (See AMZN stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
23 minutes ago
- Yahoo
North America High-Net-Worth Individual Population Surges, While Europe and Middle East Shrink: Capgemini Report
U.S. led the world in growth in its millionaire population, adding 562,000 to reach 7.9 million Ultra-high net worth individual population rises by 6.2% worldwide High-net-worth individuals now allocate 15% of their portfolios to alternative investments, including cryptocurrencies PARIS, June 04, 2025--(BUSINESS WIRE)--The Capgemini Research Institute's World Wealth Report 2025, published today, reveals the global high-net-worth individuals1 (HNWIs) population rose by 2.6% in 2024. Now in its 29th edition, the report finds this increase was driven by the growth in the population of ultra-high-net-worth individuals (UHNWIs), which grew by 6.2%, as strong stock markets and AI optimism boosted portfolio returns. The data indicates that alternative investments2, such as private equity and cryptocurrencies, are now an established presence in HNWI holdings, representing 15% of their portfolios. Bullish stock market performance in the U.S. fuels wealth increaseA favorable interest rate environment and strong U.S. equity market returns helped boost wealth creation in 2024. North America saw the biggest gains, with the HNWI population rising by 7.3%. In contrast, Europe, Latin America and the Middle East saw declines in their HNWI populations, as macroeconomic challenges weighed. At the end of 2024, according to Capgemini's research: Europe's HNWI population declined 2.1% due to economic stagnation in major countries, with United Kingdom, France and Germany losing 14,000, 21,000 and 41,000 millionaires, respectively. In contrast, Europe's UHNWI population rose 3.5%, reflecting increased wealth concentration. Asia-Pacific's HNWI population increased 2.7%, with notable variability across the region. Latin America's HNWI population declined 8.5%, due to currency depreciation and fiscal instability. Brazil (-13.3%) and Mexico (-13.5%) witnessed the biggest population declines. The Middle East's HNWI population declined 2.1%, driven by lower oil prices. Within the largest individual markets, the U.S. was the clear leader, adding 562,000 millionaires as the country's HNWI population grew by 7.6% to 7.9 million. India and Japan were standouts in the Asia-Pacific region, with both countries registering 5.6% growth, adding 20,000 and 210,000 millionaires, respectively. In contrast, growth in China was negative, with HNWI population declining by 1.0%. Next-gen HNWIs seek wealth management firms that align with investment prioritiesWealth management firms are actively preparing for a new era of wealth transfer in which 83.5 trillion USD3 will change hands over the next two decades, creating the next generation of HNWIs4. According to the report, this handover will unfold in three phases: 30% of HNWIs will receive an inheritance by the end of 2030, 63% will inherit wealth by the end of 2035, and 84% by 2040. "The great wealth transfer will be a defining moment for the industry. Despite global wealth on the rise, 81% of inheritors plan to switch firms within one to two years of inheritance. Potentially losing these unsatisfied clients is going to create significant risk for the global wealth management sector," said Kartik Ramakrishnan, CEO of Capgemini's Financial Services Strategic Business Unit and Group Executive Board Member. "The next-generation of high-net-worth individuals arrive with vastly different expectations to their parents. This necessitates an urgent shift away from traditional strategies to effectively cater to their evolving needs on this wealth journey. Firms must also prepare to equip advisors with the digital capabilities, potentially augmented with agentic or generative AI, to mitigate the risk of losing both clients and key employees." As of January 2025, HNWI investors parked 15% of their portfolios in alternative investments, including private equity and cryptocurrencies. They are willing to take more risks to expand their wealth – allocating capital to higher growth asset classes and niche product offerings, notably by 61% of millennial and Gen Z HNWIs. To attract next-gen HNWIs, wealth management firms must rethinkThe report highlights that wealth management firms need to refresh and revamp their services and offerings to resonate with the next-gen HNWI customer base. Including: Private equity and cryptocurrencies: 88% of advisors observe a greater interest in alternative assets amongst this group of investors over baby boomers New offshore booking centers: 50% of advisors indicate their lack of capabilities in emerging wealth hubs – Singapore, Hong Kong, UAE and Saudi Arabia – will drive these clients to alternate firms, as they seek diversification, better returns and a favorable regulatory environment Tailored services: concierge services such as luxury travel, medical care, and safeguarding against cyber threats, rank as the top non-financial value-added service most sought after Digital interactions: advisors rank a digital platform providing a holistic client view and actionable insights as the most important capability to effectively serve next-gen HNWIs, followed by intelligent automation of operational tasks like meeting summaries and emails Insufficient support from wealth management firms makes advisors a flight riskAccording to the report, one-in-three advisors express dissatisfaction with their firms' lack of digital capabilities, negatively impacting their productivity, and creating a technological divide. In addition, 62% of next-gen HNWIs say they would follow their advisor if they moved to a different firm. Altogether, this directly impacts retention, as advisors struggle to engage these digital-native clients. Beyond digital resources, the industry is on the cusp of a talent shortage amid an unprecedented transfer of wealth to Gen X, millennial, and Gen Z inheritors. In the next 12 months, one in four advisors plan to be on the move, with a majority transitioning to a competitor firm and a few starting their own ventures. Additionally, 20% of advisors say they will retire by 2035, with 48% planning to retire by 2040. As the great wealth transfer unfolds, the wealth management industry will need to reimagine product offerings through tailored investment options for next-gen HNWIs. Firms must empower and engage advisors with an intuitive digital experience across all channels to secure their loyalty, the report concludes. Read the full report: Sailing through the Great Wealth Transfer Report MethodologyThe World Wealth Report 2025 market-sizing model covers 71 countries, accounting for more than 98% of global gross national income and 99% of world stock market capitalization. The Capgemini 2025 Global HNW Insights Survey questioned 6,472 HNWIs including 5,473 Next-gen HNWIs across four regions: Americas, Europe, and Asia-Pacific and Middle East. The 2025 Wealth Management Executive Survey includes 141 responses across 10 markets, with representation from pure WM firms, universal banks, independent broker/dealer firms, and family offices. The 2025 Relationship Manager Survey, executed by Phronesis Partners, includes 1,306 responses across twelve markets. About CapgeminiCapgemini is a global business and technology transformation partner, helping organizations to accelerate their dual transition to a digital and sustainable world, while creating tangible impact for enterprises and society. It is a responsible and diverse group of 340,000 team members in more than 50 countries. With its strong over 55-year heritage, Capgemini is trusted by its clients to unlock the value of technology to address the entire breadth of their business needs. It delivers end-to-end services and solutions leveraging strengths from strategy and design to engineering, all fueled by its market leading capabilities in AI, generative AI, cloud and data, combined with its deep industry expertise and partner ecosystem. The Group reported 2024 global revenues of €22.1 billion. Get The Future You Want | About the Capgemini Research InstituteThe Capgemini Research Institute is Capgemini's in-house think-tank on all things digital. The Institute publishes research on the impact of digital technologies on large traditional businesses. The team draws on the worldwide network of Capgemini experts and works closely with academic and technology partners. The Institute has dedicated research centers in India, Singapore, the United Kingdom, and the United States. It was ranked #1 in the world for the quality of its research by independent analysts for six consecutive times - an industry first. Visit us at ____________________ 1 HNWIs are high-net-worth individuals with investable assets of USD1 million or more, excluding their primary residence, collectibles, consumables, and consumer durables. HNWIs are segmented into three categories based on wealth bands: Ultra-HNWIs (USD30 million or more), Mid-Tier Millionaires (USD5-30M) and Millionaires Next Door (USD1-5M). 2 Alternative investments include commodities, currencies, private equity, hedge funds, structured products, and digital assets 3 UBS, "Global Wealth Report 2024" 4 Gen X (aged 44 to 59 years as of 2025), millennial (aged 28-43 years as of 2025), and Gen Z (12 to 27 years as of 2025) inheritors are referenced as "next-gen HNWIs" to signify the generational shift in HNWI wealth View source version on Contacts Press contact: Fahd Pasha Tel.: +1 647 860 3777 E-mail: Sign in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
KATE, Japan's No. 1 Makeup Brand, Launches Strategic Initiatives to Strengthen Business and Brand Recognition Across Asia
Promoting Japanese Makeup Culture Globally and Enhancing Regional Presence TOKYO, June 04, 2025--(BUSINESS WIRE)--Kao Corporation (TOKYO:4452) has identified its international makeup brand KATE as a strategic growth driver within its cosmetics portfolio. This initiative aligns with the company's ambition to establish a "Global Sharp Top" business framework. In line with this vision, Kao is making significant investments to amplify KATE's global presence. As part of this initiative, KATE will broaden the reach of its signature "Shadow Enhancing Makeup" philosophy—a technique deeply inspired by Japan's cultural appreciation for shadows and light. In its role as Japan's No.1 makeup brand*1, KATE will also collaborate with iconic Japanese cultural content to showcase the richness of both Japanese makeup culture and the broader essence of Japanese heritage on the global stage. To enhance the brand's value, KATE will elevate the experience at its global flagship store KATE TOKYO Shibuya Sakura Stage, through immersive UX experiences. This strategic move aims to accelerate global growth, particularly across Asia. Brand Expansion Strategy in Asia Since its launch in 1997, KATE has championed the slogan "NO MORE RULES." empowering individuals to express their personality and confidence through makeup, unbound by trends or convention. Recognized for pioneering the shadow enhancing makeup technique, KATE creates striking facial dimension and expression through the interplay of light and shadow. KATE has established itself as Japan's No.1 makeup brand*1 and has played a significant role in evolving Japanese makeup culture. The brand is now expanding its signature makeup technique to consumers across Asia, where makeup culture shares many similarities with Japan, and where eye makeup plays a pivotal role. As a distinguished ambassador of Japanese makeup culture, the brand aims to transcend borders while continuing to inspire individuality and confidence in its consumers. *1 Survey by INTAGE SRI+: Cumulative sales amount in the makeup market from January 2021 to December 2024 June: Collaboration with Popular Anime "JUJUTSU KAISEN Hidden Inventory / Premature Death" *2 Beginning June 2, KATE is excited to unveil a limited-edition collaboration with the globally acclaimed comic-turned anime series JUJUTSU KAISEN. Known for its commitment to breaking conventions and fostering creative self-expression through meticulously designed products, KATE aims to inspire users to unleash their creativity. This collaboration introduces a collection of limited-edition products featuring packaging designs inspired by striking scenes that highlight the intense gaze of the iconic character Satoru Gojo. The collection will be available from June 21. Under the campaign slogan "Makeup is the most powerful spell to control your confidence", the collaboration highlights the transformative potential and creative possibilities of makeup on a global scale. To support the campaign, a dedicated photo spot featuring Satoru Gojo will be installed at the brand's flagship store, KATE TOKYO Shibuya Sakura Stage. Additionally, a special microsite will be launched on KATE's official website. The campaign will leverage a comprehensive "OMO (Online Merges with Offline)" strategy, seamlessly integrating social media platforms such as X, Instagram, and TikTok with in-store experiences and campaign video content, maximizing user interaction and engagement. Limited-Edition JUJUTSU KAISEN Collaboration Product Lineup Product Name Variants Suggested Retail Price KATE Designing Eyebrow 3D 2 types JPY 1,100 (incl. tax: JPY1,210) KATE Super Sharp Liner EX4.0 2 types JPY 1,300 (incl. tax: JPY 1,430) For more information, visit the JUJUTSU KAISEN collaboration microsite. *2 © Gege Akutami / Shueisha, JUJUTSU KAISEN Project July: "LIGHTS ON SHADOW." Collaboration with renowned Japanese artists In July, KATE is set to launch a collaboration with renowned Japanese artists popular throughout Asia. Centered on the theme "Shadow Enhancing Makeup Transcends Dimensions", this campaign illustrates how the expert application of highlights and shadows can evoke stunning beauty that bridges the two- and three-dimensional realms. In addition to product offerings, including eyeshadow and eyebrow items designed for shading techniques, the campaign will symbolically portray the process of unlocking one's individuality and gaining confidence through hyper-realistic visual techniques. Local brand ambassadors will be appointed in key Asian markets such as Taiwan and Thailand to amplify the cultural narrative and reach of Japanese makeup artistry. September: Jointly developed with Universal Studios Japan, a next-generation walkthrough attraction On September 5, KATE will unveil a collaboration with Universal Studios Japan, a popular destination for both local and international visitors. Together, they will co-create a new attraction:"Witches of House 18: Bewitching Mansion of Emotion", as part of the park's Halloween Horror Nights event. This marks the first-ever co-development of an attraction between Universal Studios Japan and an official event partner. Centered on the theme "Unleash the self hidden inside you", the experience draws out a wide range of emotions through the guidance of four witches, revealing new dimensions of the self. This collaboration between KATE and Universal Studios Japan delivers a one-of-a-kind experience, unlocking extraordinary surprises and creative freedom that empower guests to express their best selves. KATE will continue to promote Japanese makeup culture throughout Asia by engaging in ongoing media outreach and creating unique consumer experiences. With the goal of becoming Asia's No.1 makeup brand, Kao is dedicated to enhancing KATE's market presence as part of its broader strategy to build a "Global Sharp Top" cosmetics portfolio. Related Information KATE Official Brand Website KATE unveils first global flagship store (Press release from July 2024) JUJUTSU KAISEN Official TV Anime Website Universal Studios Japan Official Website KATE is the official event partner of Universal Studios Japan. HARRY POTTER and all related characters and elements © & ™ Warner Bros. Entertainment Inc. Publishing Rights © J.K. TM & © 2025 Universal Studios.© NintendoTM & © Universal Studios & Amblin EntertainmentTM & © 2025 Universal Studios. All rights reserved. CR25-1897 About Kao Kao, a Japan-based manufacturer of personal care and household products, cosmetics, and specialty chemicals creates high-value-added products and services that provide care and enrichment for the life of all people and the planet. Through its brands such as Attack laundry detergent, Bioré and Jergens skin care products, Laurier sanitary products, Curél, SENSAI, and MOLTON BROWN cosmetics, and Oribe hair care products, Kao is part of the everyday lives of people across Asia, the Americas, Europe, the Middle East, and Africa. Combined with its chemical business, which contributes to a wide range of industries, Kao generates about 1,630 billion yen in annual sales. Kao employs about 32,600 people worldwide and has more than 130 years of history in innovation. As an enterprise that provides products people use on a daily basis, the Kao Group takes responsibility to actively reduce the environmental footprint of its products throughout the product lifecycle. This is laid out in Kao's ESG strategy, the Kirei Lifestyle Plan, which launched in visit the Kao Group website for additional information. View source version on Contacts Media inquiries should be directed to: Public RelationsKao Corporationcorporate_pr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
